Melane Sampson, Author at BioTuesdays

Markets

Leerink cuts Epizyme to market perform and PT to $16

Leerink downgraded Epizyme (NASDAQ:EPZM) to “market perform” from “outperform” and lowered its price target to $16 from $24 after making extensive changes to its revenue forecasts for Epizyme’s only drug, tazemetostat...

July 3, 2018

Executive Moves

Carin Fradin joins JMP as a managing director investment banking

Carin Fradin has joined JMP Group (NYSE:JMP) as a managing director in its investment banking division.

June 19, 2018

Markets

Ladenburg cuts Flex Pharma to neutral, drops PT

Ladenburg Thalmann downgraded Flex Pharm (NASDAQ:FLKS) to “neutral” from “buy” without a price target after the company halted two Phase 2 trials. In afternoon trading on June 13, shares of Flex were quoted at $1.36...

June 13, 2018

Feature

Gecko Biomedical readies rapid acceleration of polymer platform

By Melane Sampson Since developing and validating SETALUM, a versatile vascular sealant in 2013, closely-held, Paris-based Gecko Biomedical is now poised to seek FDA approval for SETALUM, validate new programs, and open...

May 29, 2018

Markets

Canaccord cuts Vermillion to hold; PT to $1

Canaccord Genuity downgraded Vermillion (NASDAQ:VRML) to “hold” from “buy” and lowered its price target to $1 from $2.25 after the company’s first quarter results missed estimates across the board. The stock closed at...

May 24, 2018

Executive Moves

Complexa names Francisco Salva as CEO, president

Closely-held Complexa appointed Francisco Salva as the company’s new CEO and president, effective immediately.

May 14, 2018

Developments

FDA releases Theratechnologies from EGRIFTA post-approval commitments

The FDA has released Theratechnologies (TSX:TH) from post-approval commitments related to the approval of EGRIFTA. When the FDA approved EGRIFTA in 2010, the agency requested that the company conduct two large safety...

May 1, 2018

Developments

Adocia and Tonghua Dongbao in insulin strategic alliance in China

Adocia (Euronext Paris:FR0011184241 – ADOC) and Tonghua Dongbao Pharmaceuticals (Shanghai Stock Exchange 600867) announced a strategic partnership, giving Tonghua exclusive development and commercialization rights in...

April 26, 2018

Developments

CellAegis inks first distribution deal for autoRIC in Europe

Closely-held CellAegis Devices entered into a definitive agreement with Cardiologic, for the marketing and distribution of its autoRIC device in the UK and Ireland. “This marks the first distribution agreement for the...

April 24, 2018

Developments

FDA committee approves GW Pharma cannabidiol for seizures

The Peripheral and Central Nervous System Drugs Advisory Committee of the FDA unanimously recommended supporting the approval of the NDA from GW Pharmaceuticals (NASDAQ:GWPH) and its U.S. subsidiary Greenwich...

April 19, 2018

Author - Melane Sampson

Leerink cuts Epizyme to market perform and PT to $16

Carin Fradin joins JMP as a managing director investment banking

Ladenburg cuts Flex Pharma to neutral, drops PT

Gecko Biomedical readies rapid acceleration of polymer platform

Canaccord cuts Vermillion to hold; PT to $1

Complexa names Francisco Salva as CEO, president

FDA releases Theratechnologies from EGRIFTA post-approval commitments

Adocia and Tonghua Dongbao in insulin strategic alliance in China

CellAegis inks first distribution deal for autoRIC in Europe

FDA committee approves GW Pharma cannabidiol for seizures

Subscribe